Montelukast API Market Share

Montelukast API Market Share Analysis

The global market for montelukast API, a medicine used for various conditions, is divided based on where it's used. One significant category is asthma, making up almost half of the market share at 48.91% in 2017, valued at USD 592,405.8 thousand. This segment is expected to keep growing at a rate of 3.42%. The increase in asthma cases is linked to factors like genetics, exposure to allergens, air pollution, diet, and immune responses. Montelukast API is commonly used as a long-term medication for asthma, contributing to the segment's growth. Another important category is allergic rhinitis, which is expected to have the highest growth rate of 3.89% due to poor eating habits and sedentary lifestyles, reaching a value of USD 349,469.2 thousand by 2023. There's also a category labeled as "others," covering various uses like prophylaxis, cerebral spasm, hepatitis, and endotoxemia. In 2018, the asthma segment continued to dominate with a market share of 48.92%, while allergic rhinitis was the second-largest at USD 288,728.8 thousand, expected to have the highest growth rate.
The global market for montelukast API, a medicine used for various health issues, is sorted into different categories based on where it's applied. One significant category is asthma treatment, making up almost half of the market, and it's expected to keep growing. This growth is due to more people dealing with asthma, influenced by factors like genetics, exposure to allergens, air pollution, diet, and immune responses. Montelukast API is commonly used as a long-term medication for asthma, which is a key reason why this category is growing.

Another important category in the market is allergic rhinitis, expected to have the highest growth rate. This condition, linked to poor eating habits and sedentary lifestyles, is becoming more prevalent. The market reflects this by showing an increasing demand for montelukast API to address allergic rhinitis. Additionally, there's a category labeled as "others," covering various uses like prophylaxis, cerebral spasm, hepatitis, and endotoxemia. These categories provide a comprehensive understanding of how montelukast API is used across different health conditions, indicating its versatility in addressing various medical needs.